Profit finally in sight for gene therapy specialist Oxford BioBusiness InsiderLONDON, Aug 23 (Reuters) – After 20 years of losses, gene therapy specialist Oxford BioMedica is at last close to achieving its first profit thanks to the success of Novartis… Continue reading
OncLiveDr. Hammers on Next Steps with Immunotherapy in RCCOncLiveHans J. Hammers, MD, PhD, associate professor, Internal Medicine, UT Southwestern Medical Center, discusses the next steps with immunotherapy for patients with renal cell carcinoma (RCC)… Continue reading
Futurism |
CRISPR Therapeutics Joins Hospital For Cancer Treatment Tests
Futurism CRISPR Therapeutics has teamed up with General Hospital of Massachusetts to further-widen CRISPR’s near-ubiquitous applications. Within this two-year collaboration, CRISPR/Cal9 will also be used in T cell cancer therapies. CRISPR Therapeutics, MGH Partner to Develop T-Cell Cancer TherapiesGenetic Engineering & Biotechnology News Building up its I/O ops, CRISPR Therapeutics allies with Marcela Maus at Mass GeneralEndpoints News Mass General, CRISPR Therapeutics to Develop Cancer TherapiesGenomeWeb StreetInsider.com –BZ Weekly –Sparta Review all 9 news articles » |
WFMZ Allentown |
Health Beat: Achromatopsia: Gene therapy cures eye disease?
WFMZ Allentown GAINESVILLE, Fla. – Each time Tara Cataldo prepares to leave her house, she has to make sure her face is completely shielded from the sun. “I need to have very dark, very tinted sunglasses to feel comfortable outside and to see really well,” Cataldo said. |
|
HIV’s Cut and Paste Inspires Cancer Cure
American Council on Science and Health He developed what is known as Chimeric Antigen Receptor T–cell therapy (CAR-T) which is basically an engineered version of a patient’s own T–cells to recognize and kill cancer. In a recent interview with the Wall Street Journal, Dr. June describes how … |